North Jersey/ Health & Lifestyle

Food Allergy Institute Comes to Hoboken September 15, 2026

AI Assisted Icon
Published on October 15, 2026
Food Allergy Institute Comes to Hoboken September 15, 2026Source: National Cancer Institute / Unsplash

A California-based clinic that has spent a decade helping kids outgrow severe food allergies was coming to Hoboken on September 15, 2026, and had begun seeing patients by October 15 at 79 Hudson Street. The Food Allergy Institute's arrival gives some families in the New York metropolitan area a local option for its controversial but closely watched treatment program.

The Hoboken clinic sits inside The Lyric, a commercial building near the Hoboken PATH station, according to Hoboken Girl. The location is near the Hoboken PATH station. As Jersey Digs reports, the institute has spent recent weeks setting up systems to transfer and schedule local patients, coordinating insurance, and reaching out to the community ahead of the opening.

Dr. Inderpal Randhawa, who founded the Food Allergy Institute in 2015, said families in the New York and New Jersey area have been asking for access to the program for years, per the Jersey Digs report. The institute, which previously treated more than 11,000 patients at its California facilities, has patients who travel from out of state; more than half do so, with four to six in-person visits a year. Undark Magazine described Carrie Martin joining the waitlist and worrying about the logistics of cross-country trips. That demand is what the institute says is driving its broader expansion plans to the greater New York metropolitan area and, eventually, nationwide.

How the Program Works, and Why It's Debated

The clinic's centerpiece is its Tolerance Induction Program, which aims to help food allergy sufferers build lasting tolerance to trigger foods rather than simply avoiding them for life, and it leans on artificial intelligence to track patient progress and predict individualized treatment benchmarks. Unlike conventional oral immunotherapy, which doses patients directly with their target allergen, the institute's protocol uses machine learning to sequence non-allergenic biosimilar food proteins that downregulate immune reactivity before the primary allergen is ever introduced, the same Undark report notes.

A prospective study in the Journal of Allergy and Clinical Immunology: Global evaluated 214 children with cow's milk allergy and reported clinical outcomes, according to the peer-reviewed study hosted on PMC.

A Change.org petition calls on the institute's leadership to publish independently reviewed safety and outcome data. The program has been listed at $979 per month under all-inclusive cash pricing, while the petition says it typically costs more than $10,000 annually.

Why Demand Is Rising Now

The timing of the East Coast expansion lines up with a shrinking menu of standardized allergy treatment options. Palforzia, which became the first FDA-approved oral immunotherapy for peanut allergies back in January 2020, was scheduled for global discontinuation by manufacturer Stallergenes Greer on July 31, 2026, for commercial reasons, according to IngrediCheck.

Food allergies are also a concern for families with children. Regional lawmakers have responded to the issue too: New York enacted Elijah's Law in 2019, requiring child care and early education programs to set up standardized food allergy prevention and emergency response plans, according to The Journalist's Resource.

Ribbon-Cutting and Celebration Planned

A ribbon-cutting ceremony for the Hoboken location is scheduled for Friday in Hoboken, with Hoboken Mayor Emily Jabbour and the Hoboken City Council both invited to attend, per the Jersey Digs report. The institute is also planning a separate event the same day, the Bringing Food Freedom East celebration, at American Dream Mall.

The Food Allergy Institute's roots trace back to the Translational Pulmonary and Immunology Research Center in Long Beach, California. Whether the Hoboken clinic can build a similar presence on the East Coast while satisfying critics' calls for more independent data remains an open question families and allergists alike will be watching.